Boundless Bio Inc (BOLD)
3.31
-0.27
(-7.54%)
USD |
NASDAQ |
Nov 14, 12:55
Boundless Bio Total Assets (Quarterly): 188.20M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 188.20M |
| March 31, 2024 | 117.08M |
| December 31, 2023 | 129.89M |
| Date | Value |
|---|---|
| September 30, 2023 | 143.74M |
| June 30, 2023 | 154.93M |
| December 31, 2022 | 76.83M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
76.83M
Minimum
Dec 2022
188.20M
Maximum
Jun 2024
135.11M
Average
136.82M
Median
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 15.72M |
| IGC Pharma Inc | 10.59M |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Protalix BioTherapeutics Inc | 91.54M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 8.957M |
| Shareholders Equity (Quarterly) | 179.25M |